Skip to content

A clinical study comparing two Ayurvedic treatments for dry eyes caused by long hours of computer use by using Jeevanthyadhi Ghritha

A Randomized Comparative Clinical Trial To Assess The Efficacy Of Jeevanthyadhi Ghritha Aschyothana And Tarpana In Evaporative Dry Eye Common In Prolonged Computer Usage In Digital Life - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087733
Enrollment
176
Registered
2025-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H048- Other disorders of lacrimal system

Interventions

None listed

Sponsors

SHARON FINBE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with clinical symptoms of evaporative dry eye OSDI between 13 to 32 TBUT less than 10 sec Schirmer I test value between 5 to 15mm Subjects willing to participate for the study and have signed an informed consent Subjects who are exposed to digital screen continuosly for more than 4 hours a day No prior treatment for dry eye within the last 3 month

Exclusion criteria

Exclusion criteria: Subjects with dry eye due to systemic or auto immune disease confirmed through medical history or diagnostic testing. Subjects who suffer from aqueous deficiency dry eye Impaired eyelid function like lagophthalmos meibomian gland dysfunction Use of medication affecting tear production like antihistamines and antidepressants Recent ocular surgery or trauma within the past 6 months Contact lens wearers Pregnant or lactating women Subject with a known allergy to ingredients in Jeevanthyadhi Ghritha as assessed by medical history or allergy testing

Design outcomes

Primary

MeasureTime frame
Improvement in OSDI score at baseline to 30 th dayTimepoint: 0 day 6 day 10 day 20 day 30 day

Secondary

MeasureTime frame
Change in TBUT measured at baseline and after treatment Change in Schirmer-I test values from baseline and after treatmentTimepoint: 0 day 6 day 10 day 20 day 30 day

Countries

India

Contacts

Public ContactDr SREEKANTH N P

Research Department, Glocal University

drsreekanthnp@sreedhareeyam.com9745005914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026